Keystone Nano |
|
Keystone Nano is a development-stage company working at the interface between nanotechnology and the life sciences. Its researchers create nanoparticles that protect and selectively deliver active compounds such as chemotherapeutics or small interfering RNA to tumors. The company has licensed technology from Penn State University and is developing proprietary nanoparticle technology.
The company's venture began in the Zetachron Technology Incubator in State College, Pennsylvania and recently expanded with the addition of its second laboratory and office at HCAR. Keystone Nano is led by CEO Jeff Davidson, MBA; Chief Science Officer James Adair, PhD.; Chief Medical Officer Mark Kester, PhD; and Research Manager Mylisa Parette, Ph.D. Together with its research staff, the team is successfully transferring technology from academia to business and beyond. ContactJeffrey Davidson |
